Computer-Assisted HIV Prevention for Young Drug Users

NCT ID: NCT00182585

Last Updated: 2008-08-13

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 56 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2004-08-31

Brief Summary

In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

Detailed Description

Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.

Conditions

HIV

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Interventions

computer-based HIV, STD & Hepatitis Education

Intervention Type: PROCEDURE

educator-delivered HIV, STD and Hepatitis education

Intervention Type: PROCEDURE

Eligibility Criteria

Inclusion Criteria

• Aadolescents in outpatients substance abuse treatment
• Ages 13 - 18 years
• Within first month of treatment entry

• Minimum Eligible Age: 13 Years
• Maximum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Daytop (adolescent treament program)

UNKNOWN

Sponsor Role: collaborator

St. Luke's-Roosevelt Hospital Center

OTHER

Sponsor Role: collaborator

National Development and Research Institutes, Inc.

OTHER

Sponsor Role: lead

Principal Investigators

Lisa Marsch, PhD

Role: PRINCIPAL_INVESTIGATOR

National Development and Research Institutes, Inc.

Locations

Daytop

Brooklyn, New York, United States

St. Luke's-Hospital, CAPA Program

New York, New York, United States

Countries

United States

Other Identifiers

R01DA015964

Identifier Type: NIH

Identifier Source: org_study_id

View Link